Rajgopal Govindarajan

2.8k total citations
49 papers, 2.1k citations indexed

About

Rajgopal Govindarajan is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Rajgopal Govindarajan has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Physiology and 13 papers in Oncology. Recurrent topics in Rajgopal Govindarajan's work include Adenosine and Purinergic Signaling (17 papers), HIV/AIDS drug development and treatment (9 papers) and Epigenetics and DNA Methylation (8 papers). Rajgopal Govindarajan is often cited by papers focused on Adenosine and Purinergic Signaling (17 papers), HIV/AIDS drug development and treatment (9 papers) and Epigenetics and DNA Methylation (8 papers). Rajgopal Govindarajan collaborates with scholars based in United States, Spain and Japan. Rajgopal Govindarajan's co-authors include Premalatha Balachandran, Jashvant D. Unadkat, Sau Wai Hung, Yangzom D. Bhutia, Hardik Mody, Chung‐Ming Tse, Shanmugam Muruganandan, Christopher J. Sinal, Marçal Pastor‐Anglada and Karl A. Werbovetz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rajgopal Govindarajan

49 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajgopal Govindarajan United States 26 883 539 277 276 197 49 2.1k
Qi Liu China 29 824 0.9× 1.0k 1.9× 68 0.2× 170 0.6× 356 1.8× 111 2.5k
Amarjit S. Naura United States 30 777 0.9× 678 1.3× 107 0.4× 165 0.6× 132 0.7× 64 2.0k
Hirotami Matsuo Japan 25 890 1.0× 809 1.5× 65 0.2× 104 0.4× 135 0.7× 49 2.4k
Laurence Booth United States 31 1.6k 1.8× 582 1.1× 214 0.8× 194 0.7× 778 3.9× 93 2.6k
Henk van Lenthe Netherlands 28 1.5k 1.7× 600 1.1× 51 0.2× 122 0.4× 242 1.2× 73 2.3k
Katsuhisa Inoue Japan 30 981 1.1× 1.2k 2.2× 92 0.3× 90 0.3× 120 0.6× 100 3.0k
Hae Jin Kee South Korea 36 2.3k 2.6× 557 1.0× 74 0.3× 342 1.2× 243 1.2× 77 3.5k
Paola Signorelli Italy 27 1.8k 2.0× 469 0.9× 89 0.3× 190 0.7× 368 1.9× 63 2.9k
Rifat Pamukcu United States 28 1.5k 1.7× 681 1.3× 58 0.2× 498 1.8× 137 0.7× 50 3.5k
Hoi Young Lee South Korea 33 2.5k 2.8× 532 1.0× 227 0.8× 502 1.8× 207 1.1× 81 3.5k

Countries citing papers authored by Rajgopal Govindarajan

Since Specialization
Citations

This map shows the geographic impact of Rajgopal Govindarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajgopal Govindarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajgopal Govindarajan more than expected).

Fields of papers citing papers by Rajgopal Govindarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajgopal Govindarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajgopal Govindarajan. The network helps show where Rajgopal Govindarajan may publish in the future.

Co-authorship network of co-authors of Rajgopal Govindarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Rajgopal Govindarajan. A scholar is included among the top collaborators of Rajgopal Govindarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajgopal Govindarajan. Rajgopal Govindarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Waller, Amanda P., Amy Webb, Marina Galdino da Rocha Pitta, et al.. (2022). Selective modulator of nuclear receptor PPARγ with reduced adipogenic potential ameliorates experimental nephrotic syndrome. iScience. 25(4). 104001–104001. 2 indexed citations
3.
Ali, Syed Saqib, et al.. (2022). Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective. Cancers. 14(13). 3113–3113. 4 indexed citations
4.
Mace, Thomas A., et al.. (2022). Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacology & Therapeutics. 240. 108300–108300. 13 indexed citations
5.
Nayak, Debasis, Avinash K. Persaud, Reena Shakya, et al.. (2022). EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer. iScience. 25(5). 104193–104193. 5 indexed citations
6.
Cianciolo, Rachel E., et al.. (2022). Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6. Frontiers in Cell and Developmental Biology. 10. 924751–924751. 9 indexed citations
7.
Sharma, Pankaj, et al.. (2021). Imidazoles as Potential Anticancer Agents: An Update on Recent Studies. Molecules. 26(14). 4213–4213. 125 indexed citations
8.
Persaud, Avinash K., Debasis Nayak, Craig A. McElroy, et al.. (2021). Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors. Nature Communications. 12(1). 1248–1248. 10 indexed citations
9.
Nayak, Debasis, Avinash K. Persaud, Sau Wai Hung, et al.. (2020). EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1. Molecular Cancer Therapeutics. 20(2). 410–422. 34 indexed citations
10.
Mody, Hardik, et al.. (2017). miR-202 Diminishes TGFβ Receptors and Attenuates TGFβ1-Induced EMT in Pancreatic Cancer. Molecular Cancer Research. 15(8). 1029–1039. 38 indexed citations
11.
12.
Endres, Christopher J., Aaron M. Moss, Kazuya Ishida, Rajgopal Govindarajan, & Jashvant D. Unadkat. (2016). The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse. Biopharmaceutics & Drug Disposition. 37(6). 336–344. 10 indexed citations
13.
Bolze, Alexandre, Avinash Abhyankar, Audrey V. Grant, et al.. (2012). A Mild Form of SLC29A3 Disorder: A Frameshift Deletion Leads to the Paradoxical Translation of an Otherwise Noncoding mRNA Splice Variant. PLoS ONE. 7(1). e29708–e29708. 44 indexed citations
14.
Hung, Sau Wai, Hardik Mody, & Rajgopal Govindarajan. (2012). Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge. Cancer Letters. 320(2). 138–149. 70 indexed citations
15.
Bhutia, Yangzom D., et al.. (2011). CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells. Cancer Research. 71(5). 1825–1835. 84 indexed citations
16.
Bhutia, Yangzom D., et al.. (2010). Human Equilibrative Nucleoside Transporter-3 (hENT3) Spectrum Disorder Mutations Impair Nucleoside Transport, Protein Localization, and Stability. Journal of Biological Chemistry. 285(36). 28343–28352. 77 indexed citations
17.
Endres, Christopher J., Aaron M. Moss, Rajgopal Govindarajan, et al.. (2009). The Role of the Equilibrative Nucleoside Transporter 1 (ENT1) in Transport and Metabolism of Ribavirin by Human and Wild-Type or Ent1(-/-) Mouse Erythrocytes. Journal of Pharmacology and Experimental Therapeutics. 329(1). 387–398. 54 indexed citations
18.
Mikheev, Andrei M., Tomohiro Nabekura, Amal Kaddoumi, et al.. (2008). Profiling Gene Expression in Human Placentae of Different Gestational Ages: An OPRU Network and UW SCOR Study. Reproductive Sciences. 15(9). 866–877. 106 indexed citations
19.
Govindarajan, Rajgopal, Christopher J. Endres, Dale Whittington, et al.. (2008). Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(3). G570–G580. 58 indexed citations
20.
Balachandran, Premalatha & Rajgopal Govindarajan. (2007). Ayurvedic drug discovery. Expert Opinion on Drug Discovery. 2(12). 1631–1652. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Liu Breakdown of academic impact, for papers by Amarjit S. Naura Breakdown of academic impact, for papers by Hirotami Matsuo Breakdown of academic impact, for papers by Laurence Booth Breakdown of academic impact, for papers by Henk van Lenthe Breakdown of academic impact, for papers by Katsuhisa Inoue Breakdown of academic impact, for papers by Hae Jin Kee Breakdown of academic impact, for papers by Paola Signorelli Breakdown of academic impact, for papers by Rifat Pamukcu Breakdown of academic impact, for papers by Hoi Young Lee
Rankless by CCL
2026